Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Stutman

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|October 1, 1990
Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosisJ C Akaniro, C E Vidaurre, H R Stutman, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1990
In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputumA G Arguedas, J C Akaniro, H R Stutman, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1990
In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputumH R Stutman, J C Akaniro, C E Vidaurre, et al.
Chemotherapy|January 1, 1985
Penetration of latamoxef, cefoperazone and piperacillin into the sputum of patients with cystic fibrosisC Laferriere, H R Stutman, M I Marks, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1984
In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patientsH R Stutman, D F Welch, R K Scribner, et al.
The Laryngoscope|May 1, 1984
Phaeohyphomycosis of the maxilloethmoid sinus caused by Drechslera spicifera: a new fungal pathogenS M Sobol, R G Love, H R Stutman, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1992
In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patientsJ C Akaniro, H R Stutman, A G Arguedas, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1992
In vitro activity of teicoplanin compared with vancomycin against methicillin-resistant Staphylococcus aureus derived from cystic fibrosis sputumA C Arrieta, H R Stutman, J C Akaniro, et al.
Clinical Pediatrics|August 1, 1993
Clinical profile of pediatric patients hospitalized with respiratory syncytial virus infectionW V La Via, S W Grant, H R Stutman, et al.
American Journal of Diseases of Children (1960)|November 1, 1986
Aztreonam therapy for serious gram-negative infections in childrenH R Stutman, S A Chartrand, T Tolentino, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|October 1, 1990
Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosisJ C Akaniro, C E Vidaurre, H R Stutman, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1990
In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputumA G Arguedas, J C Akaniro, H R Stutman, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1990
In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputumH R Stutman, J C Akaniro, C E Vidaurre, et al.
Chemotherapy|January 1, 1985
Penetration of latamoxef, cefoperazone and piperacillin into the sputum of patients with cystic fibrosisC Laferriere, H R Stutman, M I Marks, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1984
In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patientsH R Stutman, D F Welch, R K Scribner, et al.
The Laryngoscope|May 1, 1984
Phaeohyphomycosis of the maxilloethmoid sinus caused by Drechslera spicifera: a new fungal pathogenS M Sobol, R G Love, H R Stutman, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1992
In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patientsJ C Akaniro, H R Stutman, A G Arguedas, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1992
In vitro activity of teicoplanin compared with vancomycin against methicillin-resistant Staphylococcus aureus derived from cystic fibrosis sputumA C Arrieta, H R Stutman, J C Akaniro, et al.
Clinical Pediatrics|August 1, 1993
Clinical profile of pediatric patients hospitalized with respiratory syncytial virus infectionW V La Via, S W Grant, H R Stutman, et al.
American Journal of Diseases of Children (1960)|November 1, 1986
Aztreonam therapy for serious gram-negative infections in childrenH R Stutman, S A Chartrand, T Tolentino, et al.
Pageof 6